Hyperbaric oxygen therapy heals radiation damage to the abdomen and pelvis
Hyperbaric oxygen therapy heals radiation damage to the abdomen and pelvis
Understanding radiation damage to the abdomen and how oxygen therapy reverses it
Radiation therapy directed at abdominal and pelvic tumors saves lives but can cause significant collateral damage to healthy tissue. This includes enteritis (intestinal inflammation), proctitis (rectal inflammation), cystitis (bladder irritation), fibrosis (tissue scarring) and vascular injury. These radiation injuries can cause chronic pain, bleeding, diarrhea, urinary problems and difficulty controlling bowel function.
The damage occurs because radiation destroys blood vessel linings through obliterative endarteritis, creating tissue that becomes progressively hypovascular, hypoxic and hypocellular. These injuries can appear months to years after radiation treatment and worsen over time. HBOT directly reverses this damage by regrowing blood vessels, restoring oxygen delivery and regenerating healthy tissue in the affected organs. The FDA, AMA and Medicare approve HBOT for delayed radiation injuries.
Chronic abdominal pain, bleeding and diarrhea
Intestinal inflammation (enteritis) and rectal inflammation (proctitis)
Bladder irritation, urinary urgency and incontinence
Tissue scarring (fibrosis) and progressive organ dysfunction
How pressurized oxygen reverses radiation damage throughout the abdomen
HBOT directly addresses the three hallmarks of radiation injury — hypovascularity, hypoxia and hypocellularity — restoring function across all affected organs.
Reduces long-term radiation damage across abdominal organs
Prevents bone death in irradiated areas
Improves pain, symptoms and quality of life
Resolves hemorrhagic cystitis in over 50% of patients
Regrows blood vessels and restores tissue oxygenation
Reduces fibrosis and restores tissue flexibility
For Providers
Clinical evidence for HBOT in abdominal and pelvic radiation injuries
Hyperbaric oxygen therapy for delayed radiation injuries to the abdomen and pelvis is supported by extensive clinical evidence and approved by the FDA, AMA and Medicare.
Comprehensive evidence review: A 2021 bibliographic review (Fernandez et al.) evaluating HBOT for radiation-induced toxicities found Grade B and C evidence supporting its use across multiple abdominal and pelvic indications. HBOT demonstrated efficacy in reducing late-onset radiation injuries to the intestines, rectum, bladder and surrounding tissues.
Symptom and quality of life improvement: A large retrospective study in breast cancer patients with radiation-induced toxicities showed that HBOT significantly improves patient-reported pain scores (EQ-5D and NRS) and overall quality of life measures. These improvements were sustained beyond the treatment period.
Hemorrhagic cystitis: Studies demonstrate that over 50% of patients with radiation-induced hemorrhagic cystitis experience clinical benefit from HBOT, with complete or significant partial resolution of bladder bleeding and urinary symptoms.
Mechanism of action: Radiation damages abdominal tissue through obliterative endarteritis, creating a progressive cycle of hypovascularity, hypoxia and hypocellularity. HBOT reverses all three by stimulating angiogenesis (new blood vessel growth), delivering 1,200% more oxygen to hypoxic tissue and mobilizing stem cells for tissue regeneration. These mechanisms enable the intestines, rectum, bladder and surrounding tissue to regenerate.
Safety with cancer history: Over 50 years of research confirms that HBOT does not stimulate cancer cell growth or tumor recurrence. It is specifically designed to heal the collateral tissue damage caused by the radiation therapy used to fight cancer.
HBOT Demonstrates Efficacy in Mitigating Radiation-Induced Toxicities and Enhancing Radiotherapy Outcomes
This large study of consecutive breast cancer patients with late radiation toxicity shows a beneficial effect of HBOT on patient-reported symptoms and quality of life and functioning until at least three months after HBOT.
According to a bibliographic review, hyperbaric oxygen therapy (HBOT) has emerged as a promising treatment for managing radiation-induced toxicity and enhancing the efficacy of radiotherapy. Approximately 5% of cancer patients treated with radiotherapy experience severe late-onset toxicity. HBOT has been used for decades to treat radiation injuries, with data from small studies and case reports. The review found Grade B and C evidence that HBOT at pressures exceeding 2 absolute atmospheres (ata) can reduce late-onset radiation injuries to the head and neck, bone, prostate, and bladder, prevent osteoradionecrosis after exodontia in irradiated areas, increase the effectiveness of radiation in head and neck tumors, and achieve promising results in the local control of high-grade gliomas. This is likely due to HBOT's ability to increase oxygen tension in tissues, which could theoretically enhance the efficiency of radiotherapy. Overall, the findings suggest HBOT is a valuable tool for clinicians managing radiation-related complications and optimizing radiotherapy outcomes. Fernández, E., Morillo, V., Salvador, M. et al. Hyperbaric oxygen and radiation therapy: a review. Clin Transl Oncol 23, 1047–1053 (2021). https://doi.org/10.1007/s12094-020-02513-5HBOT Improves Symptoms and Quality of Life in Breast Cancer Patients with Radiation-Induced Toxicities
We present the effect of hyperbaric oxygen therapy (HBOT) after radiotherapy for cancer in the pelvic cavity resulting in hematuria. Increasing the pressure of oxygen (PO2) in ischemic tissues favors the formation of new blood vessels and increases the secretion of collagen.
In a large retrospective analysis of over 1,000 breast cancer patients with late radiation toxicities, hyperbaric oxygen therapy (HBOT) was shown to significantly improve a range of clinical outcomes. After HBOT treatment, patients reported decreased pain scores, reduced breast and arm symptoms, and improved quality of life measures compared to baseline. The most common side effects were mild, including myopia and barotrauma, with only 3.2% experiencing moderate to severe effects. Factors associated with persistent breast pain after HBOT included active smoking during treatment and a shorter time (median 17.5 months) since completing radiotherapy. These findings demonstrate the efficacy of HBOT in mitigating the debilitating long-term effects of radiation therapy in breast cancer patients and support its use as a valuable management strategy for this patient population. Batenburg MCT, Maarse W, van der Leij F, et al. The impact of hyperbaric oxygen therapy on late radiation toxicity and quality of life in breast cancer patients. Breast Cancer Res Treat. 2021;189(2):425-433. doi:10.1007/s10549-021-06332-2THE EFFICACY OF HYPERBARIC OXYGEN THERAPY IN THE TREATMENT OF RADIATION-INDUCED LATE SIDE EFFECTS
Our retrospective study indicates that HBOT seems to be an efficacious treatment modality for many radiation-induced late side effects.
In recent years, our understanding of the underlying mechanisms of late radiation-induced side effects has increased. Although cellular depletion and tissue devascularization were originally thought of as being the predominant pathologic basis for these side effects, they represent merely a histopathologic marker for a far more complex and clinically diverse problemRadiation damage patients share their recovery stories
Lisa, 44
Jennifer, 68
Your path from radiation damage to restored abdominal function
We design a personalized HBOT protocol based on your radiation history, affected organs and symptom severity.
Comprehensive radiation injury assessment
Our medical team reviews your radiation history, current symptoms, imaging and previous treatments to design a targeted HBOT protocol coordinated with your oncologist.
Daily HBOT sessions in our pressurized chambers
You breathe 100% oxygen in a pressurized chamber for approximately 90 minutes per session. Abdominal radiation damage protocols typically involve 30 to 60 sessions.
Progressive symptom relief and tissue regeneration
We track symptom improvement throughout treatment. Most patients experience progressive reduction in pain, bleeding, diarrhea and urinary symptoms as tissue regenerates.
Frequently Asked Questions
Answers to the questions patients ask most about hyperbaric oxygen therapy for radiation damage to the abdomen and pelvis.
HBOT treats the full range of radiation-induced abdominal and pelvic injuries including enteritis (intestinal inflammation), proctitis (rectal inflammation and bleeding), cystitis (bladder damage and bleeding), fibrosis (tissue scarring), vascular injury, vaginal fissures and rectal fissures.
Start healing your radiation damage today
Schedule a free consultation to discuss how hyperbaric oxygen therapy can heal your abdominal and pelvic radiation injuries and restore your quality of life.
